Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Suma Krishnan currently holds 1,478,056 shares of Krystal Biotech, Inc. (KRYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Suma Krishnan has been a net seller of KRYS stock. They have purchased $2.1M and sold $104.9M worth of shares.
Suma Krishnan's most recent insider trade was on Dec 5, 2025, when they sold 5,000 shares at $0.00 per share.
Suma Krishnan serves as Executive at Krystal Biotech, Inc. (KRYS). They have executed 213 insider transactions totaling $107.0M over their tenure at the company.
Suma Krishnan holds the position of Executive at Krystal Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Suma Krishnan has shown a selling trading pattern, with $2.1M in total purchases and $104.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Suma Krishnan was on Dec 4, 2025, when they sold $2.3M worth of KRYS shares. This transaction involved 10,505 shares at $221.78 per share.
Suma Krishnan currently owns 1,478,056 shares of Krystal Biotech, Inc. (KRYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Suma Krishnan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Suma Krishnan has 213 Form 4 filings on record as an insider at Krystal Biotech, Inc..
Set alerts for Suma Krishnan and 40,000+ other insiders.